Home » today » World » EU green light for second ‘COVID-19’ vaccine after 94.1% positive results

EU green light for second ‘COVID-19’ vaccine after 94.1% positive results

Brussels, Jan. 7 (Xinhua) – The European Union (EU) on Wednesday approved a vaccine against the novel coronavirus (COVID-19). 2nd among member countries After the scientific evaluation from the European Medicines Agency has been positive.

The European Commission (EC) has approved the conditional distribution of the COVID-19 vaccine. Developed by Moderna (Moderna), a US pharmaceutical company. The decision has been approved by the Member States.

“We will have an additional 160 million doses of the vaccine after Moderna. This is the second COVID-19 vaccine approved in the EU, ”said Commission Chair Ursula von Der Lieen, adding that “We will have more vaccines in the future.”

On Wednesday (6 Jan), the European Medicines Agency (EMA) directed approval of the conditional commercialization of Moderna vaccines. After assessment of the quality, safety and efficacy of the vaccine

The WHO said the vaccine was proven to be effective for people 18 years and older during a large clinical trial of 30,000 participants, with an efficacy of 94.1 percent of all sex participants. Race and ethnicity Those at risk of severe COVID-19, such as chronic patients with lung disease, heart disease, obesity, liver disease or people with HIV (HIV), vaccine efficacy was reduced to 90.9 percent.

Earlier, the EU launched a COVID-19 vaccine. The first is jointly developed by Pfizer and BioNtech, approved by the WTO. It was approved for conditional sale by the commission on 21 Dec 2020.

The European Center for Disease Control and Prevention (ECDC) said that until the last week of last year. The EU and the UK have reported more than 17 million COVID-19 cases and 1.8 million deaths since the European pandemic in February 2020.

As the world struggles to stop the spread of COVID-19 Some countries are already working on vaccinations that have already been approved by the World Health Organization (WHO), with a report on Dec. 29 that worldwide is developing 232 COVID-19 vaccines, with 60 vaccines. It is currently undergoing clinical trials in countries such as Germany, China, Russia, the United Kingdom and the United States.


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.